Last Updated: Friday, December 28, 2012, 00:24
US-based drug maker Bristol-Myers Squibb Company has filed patent infringement case against Dr Reddy's Laboratories (DRL) over the cancer drug Ixempra.
Last Updated: Friday, November 16, 2012, 15:04
Biotechnology major Biocon on Friday said it has entered into an agreement with Bristol-Myers Squibb for it's oral insulin new drug candidate IN-105.
more videos >>